<DOC>
	<DOC>NCT02609620</DOC>
	<brief_summary>This study is designated to test the safety and initial efficacy of the LunGuard's PFT device for reduction of GER. Enterally-Fed, Sedated and Mechanically Ventilated Critically Ill Patients in the ICU will have the PFT positioned in them and used for feeding of a Nutritional Formula.Samples will be taken by suction on predetermined intervals and analysed for Pepsin A concentration. The PFT will be removed upon completion of the study's scheduled routine. Patients in the control group will have a standard polyurethane nasogastric device inserted according to standard procedure, which is considered the gold standard.</brief_summary>
	<brief_title>Safety &amp; Initial Efficacy of the LunGuard PFT Sys. on Enteral-Fed, Sedated and Mechanically Ventilated Patients Peristaltic Feeding Tube</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<criteria>Informed consent. Patients who are expected for at least 12 hours to be: Mechanically ventilated and sedated. Requiring a nasogastric tube. Included are: Patients who have undergone tracheostomy. Patients who require use of prokinetic drugs and proton pump inhibitors. All levels of Gastric Residual Volume (GRV) â€¢ Patients with a contraindication for insertion of a nasogastric tube. Patients with a known esophageal obstruction, preventing passage of the device. Esophageal disease including: achalasia, hiatal hernia or any other anatomical anomaly and/or esophageal pathology, esophagitis, Zenkers diverticulum, paraesophageal hernia, esophageal varices. (not excluded are minor GERD patients) Acute and severe coagulation disorders (INR&gt; 2 or platelets below 30,000) Diabetic patients with documented gastrointestinal neuropathy Pregnancy or lactation Allergy to Silicon Patients who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the patient's participation in this study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>